Editorial Board ::: Current Signal Transduction Therapy

ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)


Volume 12, 2 Issues, 2017


Download PDF Flyer




Current Signal Transduction Therapy

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Jingxuan Yang (Biography
Jingxuan Yang

Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.

Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.

)

The University of Oklahoma Health Science Center
Oklahoma City, OK
USA



Co-Editor:

Min Li (Biography
Min Li

Dr. Min Li is Professor of Medicine, Surgery, and Cell Biology, and holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment. He is the Director of GI Cancer Research, Department of Medicine, and Vice Chair for Research, Department of Surgery, at The University of Oklahoma Health Sciences Center. He is a leading expert on pancreatic cancer. His research mainly focuses on studying pancreatic cancer (PC) pathogenesis and developing new therapies. Dr. Li’s group has published more than 140 papers, and obtained both federal (3 active NIH R01 grants) and private foundation grants to support his research. He is also a member of many NIH study sections.

)

The University of Oklahoma Health Sciences Center
Oklahoma City, OK 73104
USA


Associate Editor:

Jian’an Wang
Zhejiang University School of Medicine
Hangzhou
China


Regional Editors:

Region: Asia
Tao Jiang (Biography
Tao Jiang

Dr. Jiang is the Vice Director of Beijing Neurosurgical Institute and Department of Neurosurgery, Beijing Tiantan Hospital, which is one of the world’s largest neurosurgical centers. Dr. Jiang has more than 20 years’ working experience on both clinical practice and scientific research of neurosurgery, and performs more than 500 cases of neurosurgical operations per year. Dr. Jiang has published more than 100 manuscripts and won more than ten national and provincial awards. Dr. Jiang also serves as Chairman of GBM AGILE Executive Committee China Liaison; Chairman of Society for Neuro-oncology of China, Chinese Medical Doctor Association; Vice Dean of Department of Clinical Oncology, Capital Medical University.

)

Capital Medical University
Beijing
China

Book Review Editor:

Wenbin Li
Capital Medical University
Beijing
China


Editorial Board Members:

A. Almasan (Biography
A. Almasan

Dr. Almasan is a Professor of Molecular Medicine at Cleveland Clinic Lerner College of Medicine and co-leader of the Case Comprehensive Cancer Center. For over 20 years, his lab has had a long-standing interest in cell death and proliferation mechanisms. The focus of his research has been on the molecular basis of the DNA damage signals incurred by mammalian cells following ionizing radiation (as a prototypical DNA-damaging agent) and more recently fludarabine (in clinical use for CLL) and cell death ligands (Apo2L/TRAIL) leading to cell death and proliferation control checkpoints, autophagy, and DNA repair. Notably, Dr. Almasan has authored more than 90 pubmed-indexed manuscripts.

)

Cleveland Clinic Lerner College of Medicine
Cleveland, OH
USA

G. Banhegyi
Semmelweis University
Budapest
Hungary

Y. Cao
Karolinska Institute
Stockholm
Sweden

M. Csala
Semmelweis University
Budapest
Hungary

S. Deaglio
University of Turin
Turin
Italy

P.B. Gahan
Institut de Recherche en Cancérologie de Montpellier
Montpellier Cedex 5
France

T. Harkany
Karolinska Institute
Stockholm
Sweden

L.A. Huber
Innsbruck Medical University
Innsbruck
Austria

W.G. Jiang
Cardiff University
Cardiff
UK

M. Karin
University of California
San Diego, CA
USA

B. Klebl
GPC Biotech AG
Munich
Germany

M.S. Lesniak
The University of Chicago Hospitals
Chicago, IL
USA

Z. Liu
Xiangya Hospital, Central South University
Changsha
China

G. Müller
GPC Biotech AG
Munich
Germany

E. Nice
Ludwig Institute for Cancer Research
Parkville
Australia

A.N. Odashiro
Federal University of Mato Grosso do Sul
Campo Grande, MS
Brazil

K. Podar
Jerome Lipper Multiple Myeloma Center
Boston, MA
USA

T. Robak (Biography
T. Robak

Tadeusz Robak, MD, PhD, is Professor of Hematology at the Medical University of Lodz, and Head of the Department of Hematology at Copernicus Memorial Hospital in Lodz, Poland. He is Chair of the chronic lymphocytic leukaemia (CLL) subgroup of the Polish Adult Leukemia Study Group and President of the Polish Society of Hematology. His special interests are in CLL and lymphoma, with particular emphasis on the use of purine analogues and targeted drugs. Professor Robak has been selected by the World Scientists Forum of the International Research Promotion Council for the “Eminent Scientist of the Year 2010” award in haematology-oncology.

)

Medical University of Lodz
Ciolkowskiego
Poland

H.M. Shepard
Receptor BioLogix Inc.
San Francisco, CA
USA

M. Vadas
Cryptome
Melbourne
Australia

P. Workman (Biography
P. Workman

Prof. Paul xis CEO and President of The Institute of Cancer Research (ICR), London. From 1997 - 2016 he was Director of the CRUK Cancer Therapeutics Unit at ICR – the world’s largest non-profit cancer drug discovery group. Paul has been responsible for more than 20 molecularly targeted cancer drugs entering clinical trial, including protein kinase, PI3 kinase and HSP90 inhibitors. He founded Chroma Therapeutics and Piramed Pharma and has won numerous awards, including being elected as a Fellow of the Royal Society in 2016.

)

The Institute of Cancer Research
London
UK

X. Yu
Fudan University
Shanghai
China

H. Zhang (Biography
H. Zhang

Dr. Hongtao Zhang is a Research Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine. He graduated from University of Pennsylvania in 1999 with a Ph.D. degree in Pharmacology. Currently his research focus is receptor- targeted therapies using antibodies, antibody-like proteins, and small molecules. He is also devoted to the identification of serum biomarkers that can help the diagnosis and provide therapeutic guidance for breast cancer and melanoma. He has published more than 70 articles in journals including Nature Medicine and Nature Biotechnology. Dr. Zhang is listed as inventors in 12 approved patents and some other pending patents. He serves as an editorial board member for several journals.

)

University of Pennsylvania School of Medicine
Philadelphia, PA
USA

L. Örfi
Semmelweis University
Budapest
Hungary

A. Awada (Biography
A. Awada

Ahmad Awada is head of Medical Oncology Clinic at Jules Bordet Cancer Institute Brussels, Belgium Since 2005, he is Head of the Medical Oncology Clinic. From 2011, Dr Awada was held Associate Head of Medicine Department. He has an important clinical activity in the treatment of solid tumors and particularly breast cancer. Dr. Awada took an active part in the development of new drugs (cytotoxics, molecular-targeted therapies, immunotherapy). He is membership of several international scientific societies (ASCO, EORTC, ESMO) and Professor of Clinical Medicine at the Université Libre de Bruxelles.

He published 26 book chapters and 236 articles in international publications.

)

Jules Bordet Institute
Brussels
Belgium

P.J. Barrett-Lee
Cardiff Breast Unit
Cardiff
UK

A. Chakravarti
Harvard Medical School
Boston, MA
USA

P. Czernilofsky
University of Vienna
Vienna
Austria

A. Eberle (Biography
A. Eberle

Alex N. Eberle is a biochemist and molecular biologist educated at the ETH Zurich, Switzerland, and at the MRC Laboratory of Molecular Biology, Cambridge UK. He is an emeritus professor of pathobiology and has more than 45 years of experience in the field of biomedical research and cellular signalling. He was director of the Department of Research (now named Department of Biomedicine) of the University of Basel, visiting professor at the UCLA, and vice rector of the University of Basel. Currently he is a senior fellow of the Collegium Helveticum of the ETH Zurich.

)

University of Basel
Basel
Switzerland

C. Geula
Northwestern University
Chicago, IL
USA

P. Hirth
Plexxikon Inc.
Berkeley, CA
USA

T. Hunter (Biography
T. Hunter

Tony Hunter is the Renato Dulbecco Chair in Cancer Research and an American Cancer Society Professor at the Salk Institute for Biological Studies in La Jolla. In 1979, through his work on tumor viruses, he discovered a new class of protein kinase that phosphorylates tyrosine. He has spent most of the last 35 years studying protein kinases and phosphatases, and the role of protein phosphorylation in cell proliferation and the cell cycle, and how aberrant protein phosphorylation can cause cancer. His group also works on other types of posttranslational modifications (PTMs), including ubiquitylation and sumoylation, and crosstalk between PTMs. He has received many awards for his work on tyrosine phosphorylation, and is a member of several academic societies including the US National Academy of Sciences and the Royal Society of London.

)

The Salk Institute
San Diego, CA
USA

R.L. Jones (Biography
R.L. Jones

Dr. Jones is a medical oncologist specialising in the treatment of bone and soft tissue sarcomas and Head of the Sarcoma Unit at The Royal Marsden. He has experience in conducting Phase I, II and III trials, as well translational studies in sarcoma. Dr Jones trained in medical oncology at The Royal Marsden and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington / Fred Hutchinson Cancer Research Center in Seattle. His main research interest focuses on clinical trials of novel agents and immunotherapy in sarcoma.

)

The Royal Marsden Hospital
London
UK

H. Kawamata
Medical University School of Medicine
Tochigi
Japan

E. Klein
Karolinska Institute
Stockholm
Sweden

A. Levitzki
The Hebrew University of Jerusalem
Jerusalem
Israel

A.M. Martelli
Università di Bologna
Bologna
Italy

T. Müller
University Bochum
Bochum
Germany

Y. Niibe
Toho University Omori Medical Center
Tokyo
Japan

T.W. Orlikowsky (Biography
T.W. Orlikowsky

Dr. Orlikowsky obtained a doctorate (M.D.) in Medicine from the University of Tuebingen, Germany. Professor Thorsten Orlikowsky was appointed Head of the Dept. of Neonatology at the University Childrens’ Hospital in Aachen in 2008. He spent two years of his expert training in New York with Professor Michael Hoffmann within a fellowship of the German Cancer Aid. From this work developed his new research areas “Infection Immunology” and “Neonatal Immunology”. He deals with the question of how the immunological system develops, why premature babies easily contract infections and which consequence infections have on the immune system.

)

University of Tubingen
Tubingen
Germany

R. Purohit (Biography
R. Purohit

Dr. Rituraj Purohit is a Senior Scientist at CSIR-Institute of Himalayan Bioresource Technology, India. He has nearly 11 years of experience in the academic and research in area of computational structural and in-silico cancer biology. Previously, Dr. Purohit served as a Associate Professor at Vellore Institute of Technology (VIT), University and post-doctoral researcher at Human Genetics Foundation-Torino, Italy. During his career Dr. Purohit holds a Ph.D. in Bioinformatics from VIT University and a Master of Technology from the Indian Institute of Information Technology, Allahabad. Notably, Dr. Purohit has authored more than 50 manuscripts.

)

CSIR-Institute of Himalayan Bioresource Technology
Palampur
India

M. Sato
Aichi Medical University
Nagakute
Japan

Y. Shimohigashi
Kyushu University
Fukuoka
Japan

J. Wang
Capital Medical University
Beijing
China

J. Xu
Capital Medical University
Beijing
China

H. Zeng
Center for Vascular Biology Research
Boston, MA
USA

Z. Zhu
Im Clone Systems Incorporated
New York, NY
USA

D. Banerjee (Biography
D. Banerjee

I have been involved with training individuals both in the lab as well through two Masters Programs that I direct in the Graduate School of Biomedical Sciences. I also teach in the Ph.D and Masters courses in the GSBS. Research interests include understanding the role of carcinoma associated fibroblasts (CAFs) in tumor growth and metastasis. I also serve on the editorial board of several journals and regularly review papers for many journals.

)

Rutgers, The State University of New Jersey
New Brunswick, NJ
USA

L. Buday
Semmelweis University
Budapest
Hungary

L. Chen
Capital Medical University
Beijing
China

S. Damjanovich
University of Debrecen
Debrecen
Hungary

A. Erdei
Eötvös Loránd University
Budapest
Hungary

G. Guerra
University of Molise
Campobasso
Italy

J.A. Houghton
St. Jude Children's Research Hospital
Memphis, TN
USA

Y. Ishikawa (Biography
Y. Ishikawa

Prof Ishikawa has received his MD and PhD in Yokohama City University. Currently he is working as Chair of the Cardiovascular Research Institute of Yokohama City University School of Medicine. He successfully completed his Administrative responsibilities as Dean at Yokohama. He also served as Professor of Cell Biology & Molecular Medicine and Medicine (Cardiology) as well as attending physician in cardiology at Rutgers University. He is serving as an editorial member of several reputed journals. He has authored more than 200 research articles/books. He is a member of numerous international societies such as American Heart Association, American College of Physicians, American college of Cardiology, American Society of Biochemistry and Molecular Biology, or Japanese Society of Physiology. He has been honored as Established Investigator of American Heart Association, Fellow of American College of Physician, American College of Cardiology, American Heart Association or European Society of Cardiology.

)

Yokohama City University
Yokohama
Japan

B. Kaminska (Biography
B. Kaminska

Bozena Kaminska, PhD - a head of the Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology and Director of the Postgraduate School of Molecular Medicine, Warsaw Medical University. She graduated in 1985 from the University of Warsaw; received Ph.D. in biochemistry (1991) at the Nencki Institute, did postdoctoral training at the McGill University, Canada and UCLA, USA, has got a national Professorship in 2003. Promoted 24 PhD students. Published 110 publications in PUBMED journals, 3215 citations, H-index = 33. She organizes conferences Brain Tumors: from biology to therapy 2012, 2014, 2016 in Warsaw.

)

Nencki Institute of Experimental Biology
Warsaw
Poland

M.F. Kiani (Biography
M.F. Kiani

Dr. Kiani is a professor in the Departments of Mechanical Engineering, Bioengineering and Department of Radiation Oncology, at Temple University. He served as the chair of Department of Mechanical Engineering at Temple University (2004-2014) and Department of Biomedical Engineering at the University of Tennessee Health Science Center (2003-2004). His expertise include microfluidics, targeted drug delivery and radiation biology. He has published more than 75 peer reviewed scientific articles and has made more than 200 presentations at scientific meetings. Dr. Kiani is a fellow of the American Heart Association.

)

Temple University
Philadelphia, PA
USA

D. Kofler
University Hospital Cologne
Cologne
Germany

T.-S. Li
Yamaguchi University Graduate School of Medicine
Yamaguchi
Japan

F. Moccia
University of Pavia
Pavia
Italy

H.B. Newton
Ohio State University Hospitals
Columbus, Ohio
USA

M. Ocker (Biography
M. Ocker

Matthias Ocker studied medicine at the University of Erlangen, Germany, where he obtained his medical doctorate degree in 2000. He got his academic training at the Department of Cellular and Molecular Physiology and the Department of Gastroenterology of the University Hospital Erlangen. He became Assistant Professor for Experimental Medicine and head of research at the Department of Gastroenterology in Erlangen and was appointed full professor of Medicine and Director of the Institute for Surgical Research at the University of Marburg in 2009. He joined Bayer as Director of Experimental Medicine Oncology in Berlin in 2012 and was appointed as VP and Head of Oncology Biomarker Strategists in 2016. He is adjunct professor of Experimental Medicine at the Charité University Hospital Berlin and has authored more than 100 scientific publications.

)

Bayer Pharma Aktiengesellschaft
Berlin
Germany

A.G. Papavassiliou
University of Athens
Athens
Greece

P. Rameshwar (Biography
P. Rameshwar

Dr. Pranela Rameshwar is a professor of Medicine, Division of Hematology and Oncology at the Rutgers New Jersey Medical School. She received a B.S. degree in medical microbiology from the University of Wisconsin at Madison and a Ph.D. in biology from Rutgers University, New Jersey. Dr. Rameshwar’s research interest is in the translation of stem cell, breast cancer dormancy, neural regulation of hematopoiesis, resistance of glioblastoma and immunology of human mesenchymal stem cells. Dr. Rameshwar has authored >200 publications and give research nationally and internationally.

)

UMDNJ-New Jersey Medical School
Newark, NJ
USA

L.K. Shawver
Phenomix Corporation
San Diego, CA
USA

Y. Tutar (Biography
Y. Tutar

Dr. Yusuf Tutar is the Head of Biochemistry Division and the Head of Basic Sciences Department at Faculty of Pharmacy, Cumhuriyet University, Sivas Turkey. Dr. Tutar is also the Head of Biomedical Engineering Program at the same university. He obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.

)

Cumhuriyet University
Sivas
Turkey

A.F. Wilks
Cytopia Ltd.
Melbourne
Australia

Y. Yarden
The Weizmann Institute of Science
Rehovot
Israel

D. Zhang (Biography
D. Zhang

Dr. Zhang is Assistant President & Chief Physician & Associate Professor & the Director of the Third Department of Reproductive Endocrinology of Women's Hospital, School of Medicine, Zhejiang University. She also serves as the Assistant Director of Key Laboratory of Reproductive Genetics (Ministry of Education), Zhejiang University. Dr. Zhang has 15 years of experience in reproductive clinical work and research. She has authored more than 30 manuscripts, 2 patents, and has co-edited 3 books including “Gamete and Embryo-Fetal Origins of Adult Diseases” published by Springer.

)

Zhejiang University
Hangzhou
P.R.China

A. de Bartolomeis
Medical School of Naples Federico II
Naples
Italy


Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science